Parnell Pharmaceuticals Holding (PARN) 4.19

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 10:10 PM

Parnell Pharmaceuticals Holding (PARN) 4.19 $PARN

Parnell Pharmaceuticals' (PARN) CEO Robert Joseph on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Apr 22, 3:11PM CDT

PARN: 4.19 (-0.30)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 11:45AM CDT

AEC: 28.49 (+4.01), SMCI: 31.90 (-2.91), CAMP: 20.87 (+4.19), GEVO: 2.79 (+0.78), DSKX: 1.64 (+0.30), CCIH: 14.86 (+2.54), ENZN: 1.70 (+0.20), NRP: 5.54 (-1.38), PARN: 4.19 (-0.30), GBSN: 4.98 (+1.44), AMSC: 10.40 (+1.20), PW: 6.33 (-2.95), EARS: 4.65 (-0.75), EMMS: 1.61 (-0.24), COOL: 1.40 (-0.21), LOOK: 1.75 (-0.51), ONVO: 5.14 (+0.67), HMNY: 2.90 (-0.63), PKT: 11.42 (+1.91), ZHNE: 1.89 (+0.36)

Parnell Pharma Q1 results
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 7:28AM CDT

PARN: 4.19 (-0.30)

Parnell Pharma reports Q1 results
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 6:03AM CDT

PARN: 4.19 (-0.30)

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Results
GlobeNewswire - Wed Apr 22, 6:00AM CDT
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced business results for the first quarter 2015.
PARN: 4.19 (-0.30)

Parnell to Discuss First Quarter Business Performance on April 22, 2015
GlobeNewswire - Mon Apr 13, 3:56PM CDT
Parnell Pharmaceuticals Holdings Ltd. (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that the Company will report first quarter business results on April 22, 2015. As a Foreign Private Issuer, Parnell is only required to report financial results each half-year. Going forward, the Company intends to provide quarterly updates to investors for the interim quarters.
PARN: 4.19 (-0.30)

Will Parnell Pharmaceuticals (PARN) Continue to Surge Higher? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 30, 8:14AM CDT
Will Parnell Pharmaceuticals (PARN) Continue to Surge Higher?
PARN: 4.19 (-0.30)

Strength Seen in Parnell (PARN): Stock Rises 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 8:25AM CDT
Parnell (PARN) was a big mover last session, with shares rising just over 9% on the day.
PARN: 4.19 (-0.30), AKRX: 53.70 (-1.69)

Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Animal Health Summit
GlobeNewswire - Mon Mar 09, 4:00PM CDT
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that Robert Joseph, President and Chief Executive Officer, will be presenting at the Jefferies 2015 Animal Health Summit in New York on Thursday, March 26, 2015 at 11:40 AM ET.
PARN: 4.19 (-0.30)

Parnell to Report Financial Results for the Fiscal Period Ended December 31, 2014 on February 25, 2015
GlobeNewswire - Thu Feb 12, 9:11PM CST
Parnell Pharmaceuticals Holdings Ltd. (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, announced today that on February 25, 2015 at 7:00 am ET it will report financial results for the six-month period ended December 31, 2014. The six-month reporting period is part of a previously announced transition to reporting financial results on a calendar year basis (previously June 30 year-end).
PARN: 4.19 (-0.30)

Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference
GlobeNewswire - Mon Jan 12, 6:40PM CST
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that Robert Joseph, President and Chief Executive Officer, will be presenting at the Biotech Showcase Conference in San Francisco on Tuesday, January 13, 2015 at 9:30 AM PST.
PARN: 4.19 (-0.30)

Strength Seen in Parnell (PARN): Stock Moves 5.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 8:25AM CST
Parnell (PARN) was a big mover last session, with shares rising over 5% on the day.
PARN: 4.19 (-0.30), AKRX: 53.70 (-1.69)

Parnell Management Adopts 10b5-1 Trading Plans
GlobeNewswire - Fri Dec 19, 2:00PM CST
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, reported today that Robert Joseph, President and Chief Executive Offer, and Brad McCarthy, Chief Financial Officer, have each adopted a prearranged trading plan effective December 15, 2014 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and Parnell policy. The 10b5-1 plans call for the personal purchase of shares of company stock by Mr. Joseph and Mr. McCarthy in market transactions which commenced on December 17, 2014.
PARN: 4.19 (-0.30)

Parnell Announces Key Senior Management and Director Appointments
GlobeNewswire - Tue Dec 09, 4:50PM CST
Parnell Pharmaceuticals Holdings Ltd., a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced the appointments of Edward Robb, DVM as Chief Scientific Officer, Andy Ferrigno as Vice President of Global Sales and Thomas E. Duley as a member of the Board of Directors and member of the Audit Committee. Dr. Robb brings significant R&D, clinical research and product development expertise in companion and production animal veterinary medicine to Parnell. Mr. Ferrigno joins with a successful, longstanding track record in animal health sales, having served as Vice President of Sales for the Novartis' US Companion Animal Business. Mr. Duley is a partner in King & Spaulding's Silicon Valley Corporate Practice Group and has extensive experience in Life Science industry strategic partnerships, agreements and transactions.
PARN: 4.19 (-0.30)

Parnell Pharmaceuticals Holdings Ltd Announces Change in Fiscal Year-End
GlobeNewswire - Tue Dec 09, 4:28PM CST
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, reported today that the Company's Board of Directors approved a fiscal year-end change from June 30 to December 31, effective December 8, 2014. This change was made in order to align fiscal reporting with existing management processes which use calendar year planning and to provide more efficient reporting for US investors.
PARN: 4.19 (-0.30)

Parnell Pharmaceuticals Holdings Ltd to Present at Upcoming Investor Conferences
GlobeNewswire - Wed Nov 12, 3:30PM CST
Parnell Pharmaceuticals Holdings Ltd (Nasdaq

ARN), a fully integrated pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions, today announced that Robert Joseph, President and Chief Executive Officer, will present at two upcoming investor conferences:
PARN: 4.19 (-0.30)

Jaguar Animal Health postpones IPO
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 10:57AM CST

IPO: 24.98 (+0.05), JAGX: (), BIS: 30.54 (+0.15), PARN: 4.19 (-0.30), BIB: 177.06 (-0.89), IBB: 363.84 (-0.66)

Parnell Pharmaceuticals Holdings posts higher net loss after tax of AUD17.3m for fiscal 2014
M2 - Tue Sep 16, 6:23AM CDT
Pharmaceutical company Parnell Pharmaceuticals Holdings (NasdaqGM

ARN) on Monday declared a net loss after tax of AUD17.3m for the fiscal year 2014.
PARN: 4.19 (-0.30)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Luvme Hair Offers Wig Variety for Winter Fashion

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...